NCT06462664Recruiting
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia
Source: ClinicalTrials.gov · Last updated 17 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10 (estimated)
- First submitted
- 12 Jun 2024
- Start date
- 1 Jun 2024
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- University Hospital, Brest
- Diseases
- Myeloproliferative neoplasms
- NCT number
- NCT06462664
What you commit to
- Study type: Observational
- Planned participants: 10
- From 1 Jun 2024 to the primary completion date, 31 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not able to consent
Who the study is looking for
- Diagnosis of MPN in the participating center
- Over 18 yo
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu Brest Coordinator of this site? Confirm its status | Brest | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.